Abstract
The prevalence of diabetes is rising rapidly throughout the world, accompanying with the increased occurrence of cardiovascular diseases in clinic. For now, the diagnosis of diabetic cardiovascular diseases has mainly based on the measurement of glucose levels in blood and cardiac function via electrocardiogram and ultrasound cardiogram. However, growing evidence strongly suggests that the assessment of Sphingosine-1-phosphate receptor 1/3 (S1P1/3) own advantages over present measurements in predicting the risk of developing diabetic cardiovascular diseases. This hypothesis may provide concept foundation for improving early diagnosis of cardiac microangiopathy in diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
